Posted by Michael Wonder on 17 Dec 2021
Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer
17 December 2021 - Prostate Cancer Foundation of Australia has welcomed recommendations by Australia’s Pharmaceutical Benefits Advisory Committee to list two life-extending drugs for men with aggressive forms of potentially deadly prostate cancer.
The agency has recommended the listing of apalutamide (Erlyand) and olaparib (Lynparza).
